References
- Mkrtchyan G, Aleshin V, Parkhomenko Y, et al. Molecular mechanisms of the non-coenzyme action of thiamin in brain: biochemical, structural and pathway analysis. Sci Rep. 2015;5:12583.
- Hazell AS, Butterworth RF. Update of cell damage mechanisms in thiamine deficiency: focus on oxidative stress, excitotoxicity and inflammation. Alcohol Alcohol. 2009;44:141–147.
- Attaluri P, Castillo A, Edriss H, et al. Thiamine deficiency: an important consideration in critically ill patients. Am J Med Sci. 2018;356:382–390.
- de la Monte SM, Kril JJ. Human alcohol-related neuropathology. Acta Neuropathol. 2014;127:71–90.
- Rosón B, Monte R, Gamallo R, et al. Prevalence and routine assessment of unhealthy alcohol use in hospitalized patients. Eur J Intern Med. 2010;21:458–464.
- Saitz R, Freedner N, Palfai TP, et al. The severity of unhealthy alcohol use in hospitalized medical patients. the spectrum is narrow. J Gen Intern Med. 2006;21:381–385.
- Isenberg-Grzeda E, Kutner HE, Nicolson SE. Wernicke-korsakoff-syndrome: under-recognized and under-treated. Psychosomatics. 2012;53:507–516.
- Manzanares W, Hardy G. Thiamine supplementation in the critically ill. Curr Opin Clin Nutr Metab Care. 2011;14:610–617.
- Galvin R, Brathen G, Ivashynka A, et al. EFNS guidelines for diagnosis, therapy and prevention of wernicke encephalopathy. Eur J Neurol. 2010;17:1408–1418.
- Alim U, Bates D, Langevin A, et al. Thiamine prescribing practices for adult patients admitted to an internal medicine service. Can J Hosp Pharm. 2017;70:179–187.
- Day GS, Ladak S, Curley K, et al. Thiamine prescribing practices within university-affiliated hospitals: a multicenter retrospective review. J Hosp Med. 2015;10:246–253.
- Kasper DL, Fauci AS, Hauser SL, et al. Harrison’s Principles of Internal Medicine 20/E (Vol.1 \& Vol.2) (Ebook). New York: McGraw-Hill Education; 2018.
- Schabelman E, Kuo D. Glucose before thiamine for wernicke encephalopathy: a literature review. J Emerg Med. 2012;42:488–494.
- Jackson R, Teece S. Best evidence topic report. oral or intravenous thiamine in the emergency department. Emerg Med J. 2004;21:501–502.
- Woolum JA, Abner EL, Kelly A, et al. Effect of thiamine administration on lactate clearance and mortality in patients with septic shock. Crit Care Med. 2018;46:1747–1752.
- Isenberg-Grzeda E, Chabon B, Nicolson SE. Prescribing thiamine to inpatients with alcohol use disorders: how well are we doing? J Addict Med. 2014;8:1–5.
- Day GS, Ladak S, Del Campo CM. Improving thiamine prescribing at an academic hospital network using the computerized provider order entry system: a cohort study. CMAJ Open. 2020;8:E383–E390.
- Center for medicare & medicaid services. MS-DRG classifications and software [online]; Available from: https://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/AcuteInpatientPPS/MS-DRG-Classifications-and-Software
- Fujii T, Luethi N, Young PJ, et al. Effect of vitamin C, hydrocortisone, and thiamine vs hydrocortisone alone on time alive and free of vasopressor support among patients with septic shock: the VITAMINS randomized clinical trial. JAMA. 2020;323:423.
- Sevransky JE, Rothman RE, Hager DN, et al. Effect of vitamin C, thiamine, and hydrocortisone on ventilator- and vasopressor-free days in patients with sepsis: the VICTAS randomized clinical trial. JAMA. 2021;325:742–750.
- Moskowitz A, Huang DT, Hou PC, et al. Effect of ascorbic acid, corticosteroids, and thiamine on organ injury in septic shock: the ACTS randomized clinical trial. JAMA. 2020;324:642–650.
- Nakamura ZM, Deal AM, Park EM, et al. A randomized double-blind placebo-controlled trial of intravenous thiamine for prevention of delirium following allogeneic hematopoietic stem cell transplantation. J Psychosom Res. 2021;146:110503.
- Kattoor AJ, Goel A, Mehta JL. Thiamine therapy for heart failure: a promise or fiction?. Cardiovasc Drugs Ther. 2018;32:313–317.
- Smithline HA, Donnino M, Blank FSJ, et al. Supplemental thiamine for the treatment of acute heart failure syndrome: a randomized controlled trial. BMC Complement Altern Med. 2019;19: 96–019.
- Nakamura ZM, Tatreau JR, Rosenstein DL, et al. Clinical characteristics and outcomes associated with high-dose intravenous thiamine administration in patients with encephalopathy. Psychosomatics. 2018;59:379–387.
- Nishimoto A, Usery J, Winton JC, et al. High-dose parenteral thiamine in treatment of wernicke’s encephalopathy: case series and review of the literature. Vivo. 2017;31:121–124.
- Naidoo DP, Bramdev A, Cooper K. Wernicke’s encephalopathy and alcohol-related disease. Postgrad Med J. 1991;67:978–981.
- Wai JM, Aloezos C, Mowrey WB, et al. Using clinical decision support through the electronic medical record to increase prescribing of high-dose parenteral thiamine in hospitalized patients with alcohol use disorder. J Subst Abuse Treat. 2019;99:117–123. [Cited28 September 2020].
- Wang H, Johnson C, Robinson RD, et al. Roles of disease severity and post-discharge outpatient visits as predictors of hospital readmissions. BMC Health Serv Res. 2016;16: 564–016.
- Xourafas D, Merath K, Spolverato G, et al. Specific medicare severity-diagnosis related group codes increase the predictability of 30-day unplanned hospital readmission after pancreaticoduodenectomy. J Gastrointest Surg. 2018;22:1920–1927.